MedPath

HIV-Related Stigma Intervention for Malaysian Clinicians

Not Applicable
Completed
Conditions
Hiv
Registration Number
NCT05597787
Lead Sponsor
University of Delaware
Brief Summary

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • practicing general practitioner or family medicine specialist in Malaysia
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Acceptability of InterventionMonth 9 Assessment

Measured with Acceptability of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.50-5. Higher scores indicate greater acceptability.

Feasibility of InterventionMonth 9 Assessment

Measured with Feasibility of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.25-5. Higher scores indicate greater feasibility.

Stigma Reduction: PrejudiceMonth 9 Assessment

Measured with Feelings Thermometers. Positive/Negative affect is measured on 0-100 point scale, with higher scores indicating more prejudice.

Stigma Reduction: StereotypesMonth 9 Assessment

Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-3.44. Higher scores indicate greater stereotypes.

Stigma Reduction: DiscriminationMonth 9 Assessment

Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-5. Higher scores indicate greater discrimination.

Secondary Outcome Measures
NameTimeMethod
HIV Prevention Procedures: PrEP PrescriptionsCumulative over 9 month intervention

Measured with weekly diary of PrEP prescriptions. Number of PrEP prescriptions will be summed over duration of intervention.

HIV Prevention Procedures: HIV TestingCumulative over 9 month intervention

Measured with weekly diary of HIV tests performed. Number of HIV tests will be summed over duration of intervention.

Trial Locations

Locations (1)

University of Malaya

🇲🇾

Kuala Lumpur, Malaysia

University of Malaya
🇲🇾Kuala Lumpur, Malaysia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.